An Unbiased Approach To Identify Endogenous Substrates of “Histone” Deacetylase 8

Despite being extensively characterized structurally and biochemically, the functional role of histone deacetylase 8 (HDAC8) has remained largely obscure due in part to a lack of known cellular substrates. Herein, we describe an unbiased approach using chemical tools in conjunction with sophisticated proteomics methods to identify novel non-histone nuclear substrates of HDAC8, including the tumor suppressor ARID1A. These newly discovered substrates of HDAC8 are involved in diverse biological processes including mitosis, transcription, chromatin remodeling, and RNA splicing and may help guide therapeutic strategies that target the function of HDAC8.

[1]  K. Shirahige,et al.  Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors , 2014, ChemMedChem.

[2]  Kyoung-Jae Won,et al.  Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor. , 2013, Molecular cell.

[3]  P. Albers,et al.  Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. , 2013, Urologic oncology.

[4]  C. Fierke,et al.  HDAC8 substrates: Histones and beyond. , 2013, Biopolymers.

[5]  L. Tsai,et al.  The potential of HDAC inhibitors as cognitive enhancers. , 2013, Annual review of pharmacology and toxicology.

[6]  Kyoung-Jae Won,et al.  Nuclear Receptor Corepressors are Required for the Histone Deacetylase Activity of HDAC3 In Vivo , 2012, Nature Structural &Molecular Biology.

[7]  A. Kong,et al.  The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains , 2012, Oncogene.

[8]  Hiroki Tsumoto,et al.  Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries. , 2012, Journal of medicinal chemistry.

[9]  I. Shih,et al.  Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. , 2012, Neoplasia.

[10]  C. Olsen,et al.  Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro. , 2012, Angewandte Chemie.

[11]  Gabriele Gillessen-Kaesbach,et al.  HDAC8 mutations in Cornelia de Lange Syndrome affect the cohesin acetylation cycle , 2012, Nature.

[12]  F. A. Schroeder,et al.  Histone Acetylation and Deacetylation , 2012 .

[13]  T. Karagiannis,et al.  An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis. , 2012, American journal of translational research.

[14]  Chunaram Choudhary,et al.  Proteome-Wide Mapping of the Drosophila Acetylome Demonstrates a High Degree of Conservation of Lysine Acetylation , 2011, Science Signaling.

[15]  K. Jeong,et al.  Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer. , 2011, Oncology reports.

[16]  J. Bradner,et al.  On the inhibition of histone deacetylase 8. , 2010, Bioorganic & medicinal chemistry.

[17]  Brian J. Wilson,et al.  An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha. , 2010, Molecular endocrinology.

[18]  Ziv Shkedy,et al.  IsoGene: An R Package for Analyzing Dose-response Studies in Microarray Experiments , 2010, R J..

[19]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[20]  E. Olson,et al.  Epigenetic control of skull morphogenesis by histone deacetylase 8. , 2009, Genes & development.

[21]  Barbara Hero,et al.  Histone Deacetylase 8 in Neuroblastoma Tumorigenesis , 2009, Clinical Cancer Research.

[22]  Stephanie Spange,et al.  Acetylation of non-histone proteins modulates cellular signalling at multiple levels. , 2009, The international journal of biochemistry & cell biology.

[23]  Xuewen Pan,et al.  Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast. , 2008, Molecular cell.

[24]  J. Buggy,et al.  Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation , 2008, Leukemia.

[25]  E. Seto,et al.  Acetylation and deacetylation of non-histone proteins. , 2005, Gene.

[26]  A. Sparreboom,et al.  Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review , 2005, Molecular Pharmacology.

[27]  Ivan V. Gregoretti,et al.  Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.

[28]  J. Clark,et al.  Cloning and characterization of a novel human histone deacetylase, HDAC8. , 2000, The Biochemical journal.